← Back to Search

Procedure

abdominal morcellation for Uterine Fibroids

N/A
Waitlist Available
Led By Gaby Moawad, MD
Research Sponsored by Gaby Moawad
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up perioperative
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two ways of removing the uterus in pieces during minimally invasive surgery: through the vagina or a small cut in the belly. It aims to find out which method results in better surgical outcomes for women needing a hysterectomy.

Eligible Conditions
  • Uterine Fibroids

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~perioperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and perioperative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Total operative time
Secondary study objectives
Blood Loss
Intraoperative complications
Post-operative complications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: abdominal morcellationActive Control1 Intervention
Women randomized to this group will undergo abdominal morcellation.
Group II: vaginal morcellationActive Control1 Intervention
Women randomized to this group will undergo vaginal morcellation.

Find a Location

Who is running the clinical trial?

Gaby MoawadLead Sponsor
2 Previous Clinical Trials
300 Total Patients Enrolled
George Washington UniversityLead Sponsor
253 Previous Clinical Trials
466,550 Total Patients Enrolled
Gaby Moawad, MDPrincipal InvestigatorGeorge Washington University Medical Faculty Associates
1 Previous Clinical Trials
120 Total Patients Enrolled
~0 spots leftby Nov 2025